Literature DB >> 2323776

Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency. An Italian collaborative study.

M Ferrari1, M Antonelli, F Bellini, G Borgo, O Castiglione, L Curcio, B Dallapiccola, M Devoto, X Estivill, P Gasparini.   

Abstract

To determine the number and frequency of mutations that occur at the cystic fibrosis locus (CF), we have examined the allele and haplotype frequencies of eight polymorphic DNA markers linked to CF in 163 Italian patients who were sub-divided according to their clinical presentations. The distribution of haplotypes for the tightly linked polymorphisms KM.19 and XV-2c differ significantly between patients with and those without pancreatic insufficiency. The haplotype found most commonly in CF chromosomes occurs much more frequently in pancreatic insufficient than in pancreatic sufficient patients. Among the 19 pancreatic sufficient patients, 6 (31.6%) show at least one copy of the rare KM.19 = 1, XV-2c = 2 haplotype, as against 16 of 138 patients (11.6%) with pancreatic insufficiency. In addition, only 5 pancreatic sufficient patients (26.3%) are homozygous for the common 2.1 haplotype, as compared with 88 patients (63.8%) with pancreatic insufficiency. These findings support the hypothesis of allelic heterogeneity at a single locus in CF and suggest that different mutations underlie the presence or absence of pancreatic insufficiency in this disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323776     DOI: 10.1007/bf00195815

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

2.  A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands.

Authors:  X Estivill; M Farrall; P J Scambler; G M Bell; K M Hawley; N J Lench; G P Bates; H C Kruyer; P A Frederick; P Stanier
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

3.  Familial occurrence of meconium ileus.

Authors:  J L Allan; M Robbie; P D Phelan; D M Danks
Journal:  Eur J Pediatr       Date:  1981-02       Impact factor: 3.183

4.  Relative ion permeability of normal and cystic fibrosis nasal epithelium.

Authors:  M Knowles; J Gatzy; R Boucher
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis.

Authors:  C Colombo; R Maiavacca; M Ronchi; E Consalvo; M Amoretti; A Giunta
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Nov-Dec       Impact factor: 2.839

6.  Chloride impermeability in cystic fibrosis.

Authors:  P M Quinton
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

7.  Improved prognosis in CF patients with normal fat absorption.

Authors:  M Corey; K Gaskin; P Durie; H Levison; G Forstner
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984       Impact factor: 2.839

8.  Genetic differences between cystic fibrosis with and without meconium ileus.

Authors:  E Mornet; B Simon-Bouy; J L Serre; X Estivill; M Farrall; R Williamson; J Boue; A Boue
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

9.  Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker.

Authors:  L C Tsui; M Buchwald; D Barker; J C Braman; R Knowlton; J W Schumm; H Eiberg; J Mohr; D Kennedy; N Plavsic
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

10.  Localization of cystic fibrosis locus to human chromosome 7cen-q22.

Authors:  B J Wainwright; P J Scambler; J Schmidtke; E A Watson; H Y Law; M Farrall; H J Cooke; H Eiberg; R Williamson
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

View more
  2 in total

1.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

Review 2.  Cystic fibrosis. 3. Cloning the cystic fibrosis gene: implications for diagnosis and treatment.

Authors:  D J Porteous; J R Dorin
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.